Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma

The follow‐up of patients with differentiated thyroid carcinoma (DTC) is traditionally carried out with 131I whole body scan (131I WBS) and serum thyroglobulin (Tg) measurement. Neck ultrasonography (US) is also used.

[1]  Q. Duh,et al.  Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients. , 1999, Surgery.

[2]  Shinichiro,et al.  Carcinoma , 1906, The Hospital.

[3]  J. Shah,et al.  Impact of lymph node metastasis in differentiated carcinoma of the thyroid: A matched‐pair analysis , 1996, Head & neck.

[4]  J E Medina,et al.  Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. , 1991, Archives of otolaryngology--head & neck surgery.

[5]  R. Buchert,et al.  Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  L. Burmeister,et al.  Evaluation and treatment of persistent thyroglobulinemia in patients with well-differentiated thyroid cancer. , 1997, European journal of endocrinology.

[7]  J. D. Lin,et al.  Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases. , 1999, Endocrine-related cancer.

[8]  K. Ain,et al.  Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. , 1995, The Journal of clinical endocrinology and metabolism.

[9]  D. Kopans,et al.  Sonography in the follow-up of 100 patients with thyroid carcinoma. , 1987, AJR. American journal of roentgenology.

[10]  O. Ozaki,et al.  Anaplastic transformation of papillary thyroid carcinoma in recurrent disease in regional lymph nodes: A histologic and immunohistochemical study , 1999, Journal of surgical oncology.

[11]  P DESAIVE,et al.  [Thyroid cancer]. , 1951, Revue medicale de Liege.

[12]  M. Ferdeghini,et al.  Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. , 1995, Thyroid : official journal of the American Thyroid Association.

[13]  B. Cady,et al.  An expanded view of risk-group definition in differentiated thyroid carcinoma. , 1988, Surgery.

[14]  E. Mazzaferri.  An overview of the management of papillary and follicular thyroid carcinoma. , 1999, Thyroid : official journal of the American Thyroid Association.

[15]  B. Weintraub,et al.  A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. , 1999, The Journal of clinical endocrinology and metabolism.

[16]  B. O'Sullivan,et al.  A comparison of different staging systems predictability of patient outcome , 1997, Cancer.

[17]  T. Almy,et al.  Action of Acetyl-Beta-Methylcholine Chloride (Mecholyl) On The Human Colon , 1949 .

[18]  A. Ahuja,et al.  Power Doppler sonography of cervical lymphadenopathy. , 2001, Clinical radiology.

[19]  A. Ahuja,et al.  Metastatic cervical nodes in papillary carcinoma of the thyroid: ultrasound and histological correlation. , 1995, Clinical radiology.

[20]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[21]  L. Hann,et al.  Advances in the detection of residual thyroid carcinoma. , 2001, Advances in internal medicine.

[22]  I. Hay,et al.  Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic scan-negative metastases: including comments on the role of serum thyroglobulin monitoring in tumor surveillance. , 2000, Seminars in nuclear medicine.

[23]  P. Grigsby,et al.  Surveillance of patients to detect recurrent thyroid carcinoma , 1999, Cancer.

[24]  J. Shah,et al.  Differentiated carcinoma of the thyroid with extrathyroidal extension. , 1995, American journal of surgery.

[25]  J. Němec,et al.  Sonography in the evaluation of treatment of differentiated thyroid cancer. First results in 158 patients. , 1990, Neoplasma.

[26]  D. Dean,et al.  Prognostic indicators in differentiated thyroid carcinoma. , 2000, Cancer control : journal of the Moffitt Cancer Center.

[27]  B. Glaser,et al.  Recurrence‐associated mortality in patients with differentiated thyroid carcinoma , 1993, Journal of surgical oncology.

[28]  A. Pinchera,et al.  Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer. , 1992, The Journal of clinical endocrinology and metabolism.

[29]  P. Mueller,et al.  Fine-needle biopsy of cervical lymph nodes in patients with thyroid cancer: a prospective comparison of cytopathologic and tissue marker analysis. , 1993, Radiology.

[30]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[31]  E. Mazzaferri.  Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark? , 1995, The Journal of clinical endocrinology and metabolism.

[32]  M. Schlumberger,et al.  Papillary and follicular thyroid carcinoma. , 1998, The New England journal of medicine.

[33]  R. Valcavi,et al.  Role of thyroglobulin measurement in fine-needle aspiration biopsies of cervical lymph nodes in patients with differentiated thyroid cancer. , 1999, Thyroid : official journal of the American Thyroid Association.

[34]  Z. Hall.  Cancer , 1906, The Hospital.

[35]  H. Maxon.  Detection of residual and recurrent thyroid cancer by radionuclide imaging. , 1999, Thyroid : official journal of the American Thyroid Association.

[36]  G. Gong,et al.  Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. , 2000, Thyroid : official journal of the American Thyroid Association.